LLY
Eli Lilly and CompanyNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$1.01T
P/E Ratio
40.32
EPS
$28.10
Beta
0.52
52W High
$1182.73
52W Low
$619.40
50-Day MA
$996.78
200-Day MA
$958.45
Dividend Yield
0.54%
Profit Margin
35.00%
Forward P/E
31.25
PEG Ratio
1.52
About Eli Lilly and Company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Fundamentals
| Revenue (TTM) | $72.25B |
| Gross Profit (TTM) | $59.85B |
| EBITDA | $36.22B |
| Operating Margin | 49.40% |
| Return on Equity | 107.50% |
| Return on Assets | 20.70% |
| Revenue/Share (TTM) | $80.61 |
| Book Value | $34.92 |
| Price-to-Book | 32.38 |
| Price-to-Sales (TTM) | 13.98 |
| EV/Revenue | 14.51 |
| EV/EBITDA | 28.95 |
| Quarterly Earnings Growth (YoY) | 169.90% |
| Quarterly Revenue Growth (YoY) | 55.50% |
| Shares Outstanding | $891.74M |
| Float | $889.33M |
| % Insiders | 0.15% |
| % Institutions | 85.33% |
Historical Volatility
HV 10-Day
33.52%
HV 20-Day
32.52%
HV 30-Day
31.50%
HV 60-Day
36.16%
HV Rank
41.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($1215.79 target)
6
Strong Buy18
Buy5
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026